AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Extracellular Vesicles for Rejection Monitoring in Cardiac Transplantation

Recruitingn/aAges 18 Years - anyAllLaurenz Kopp Fernandes
💬

In plain words

What the trial is, and whether it could suit you

This study will analyze extracellular vesicle (EV)-derived protein profiles in heart transplantated patients during the first 15 months post-transplantation to investigate, if there are distinct EV-derived proteins or protein patterns that allow early and reliable diagnosis of acute cardiac allograft rejection. Additionally, it will explore temporal changes in the EV-derived protein profile during the early postoperative period irrespective of acute allograft rejection, and will investigate, if there are correlations between EV protein markers and imaging findings.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Subject is either on the heart transplant waiting list or is still hospitalised following HTx surgery. * Age of subject is ≥ 18 years. * Subject is female or male. * Capacity to consent. * Signed written informed consent. * For female subjects: 1. Confirmed post-menopausal state, defined as amenorrhea for at least 12 months, or 2. If being of childbearing potential: Negative highly sensitive urine or serum pregnancy test before inclusion. Exclusion Criteria: * Concurrent multiple solid organ or tissue transplants. * Prior history of any organ or cellular transplantation. * Subject suffers from an addiction or from a disease that prevents the subject from recognising nature, scope, and consequences of the study. * Subject shows an inability to comply with all the study procedures and follow-up visits. * Subject is legally detained in an official institution. * Subjects who are unwilling to consent to saving and propagation of pseudonymised medical data for study reasons. * Subject is financially dependent on the investigators or the study site.
💊

What it tests

  • Not listed
📍

Where

1 site
Deutsches Herzzentrum der Charité, Department vor cardio-thoracic and vascular surgery
Berlin, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy